13.1 Return, Reuse & Redistribution of Dispensed Drugs

13.1 Return, Reuse & Redistribution of Dispensed Drugs

MPJE Competency Statement 2.4 — "Returning or reusing drugs" is a stand-alone blueprint item, and Kentucky's answer is unusually crisp: the default is a flat prohibition with a narrowly drawn packaging exception, layered over a separate donation program that exists precisely because the prohibition is so strict.

---

1. The Board Rule: 201 KAR 2:190

The Board of Pharmacy's regulation is one sentence long in substance:

"No pharmacy, pharmacist, or agent thereof shall accept for reuse or resale a prescription drug."

The exception is equally narrow: the prohibition does not apply to sealed or unopened unit dose, unit-of-use, or tamper-resistant drug packaging. Violating 201 KAR 2:190 is unethical or unprofessional conduct under KRS 315.121 — the same statute that carries suspension and revocation.

┌─────────────────────────────────────────────────────────────────────────────┐
│              201 KAR 2:190 — THE RETURN/REUSE DECISION                      │
├─────────────────────────────────────────────────────────────────────────────┤
│ A patient brings back a dispensed prescription drug. May you take it back   │
│ into stock for reuse or resale?                                             │
│                                                                             │
│   Was it dispensed in an ordinary amber vial the patient could open?        │
│      └─> NO REUSE. Once the container leaves the pharmacy and the patient   │
│          could have accessed the contents, the chain of custody is broken.  │
│          The pharmacy may accept the drug for DESTRUCTION, but not for      │
│          RETURN TO STOCK.                                                   │
│                                                                             │
│   Is it SEALED / UNOPENED unit dose, unit-of-use, or tamper-resistant        │
│   packaging whose integrity can still be verified?                          │
│      └─> The 201 KAR 2:190 prohibition does not reach it.                    │
│                                                                             │
│ NOTE: nothing REQUIRES a pharmacist or practitioner to accept any return.   │
└─────────────────────────────────────────────────────────────────────────────┘

---

2. The Cabinet Rules: 902 KAR 55:055 and 902 KAR 55:065

The Cabinet for Health and Family Services regulates the same conduct from the drug-safety side. 902 KAR 55:055 states the prohibition on returning prescription drugs; 902 KAR 55:065 supplies the exceptions and is the more testable of the two. Its purpose statement is explicit: the regulation exists "to prevent the dispensing of prescription drugs that may be adulterated or misbranded."

Under 902 KAR 55:065, a returned prescription drug may be accepted only if all of the following are met:

1. The drug is in a sealed container by which a pharmacist employed by the dispensing pharmacy, or the dispensing practitioner, can readily determine that entry or attempted entry has not been made;
2. The container meets USP standards for storage conditions — temperature, light sensitivity, moisture, and chemical and physical stability;
3. The labeling and packaging have not been altered or defaced, and the drug's identity, potency, lot number, and expiration date remain legible;
4. The drug does not require refrigeration; and
5. The drug is returned to a pharmacist employed by the dispensing pharmacy, or to the dispensing practitioner, within fourteen (14) days.

The Health-Care-Facility Waiver

Conditions (4) — no refrigeration and (5) — the 14-day window are waived if every other condition is met and:

• the drug was dispensed for a patient in a health care facility licensed by the Cabinet;
• the drug never came into the physical possession of the person for whom it was prescribed;
• the drug was under the continuous control of facility personnel trained and knowledgeable in the storage and administration of drugs;
• the drug was properly stored in an area regularly inspected by a pharmacist; and
• the drug is not expired.

Separately, drugs distributed within an acute care facility are exempt from conditions (1), (4), and (5).

Finally, nothing in 902 KAR 55:065 requires a pharmacist or practitioner to accept the return of a prescription drug. Acceptance is permissive, never compulsory.

Exam Trap — refrigeration is the silent disqualifier. Items describe an unopened, unexpired, sealed insulin pen box or a sealed carton of a biologic returned by a patient two days after dispensing. Every visible element looks compliant, but 902 KAR 55:065(1)(d) disqualifies any drug that requires refrigeration unless the health-care-facility waiver applies — and a community patient's return does not qualify for that waiver, because the drug came into the patient's physical possession.

---

3. Controlled Substances Are a Separate Analysis

Nothing above authorizes taking a controlled substance back into dispensing stock. Once a controlled substance has been dispensed to an ultimate user, the pharmacy's lawful options are governed by the federal Disposal Act framework and 902 KAR 55:120 (Disposal of prescription controlled substances):

Exam Trap — Form 41 versus Form 106. Form 41 records destruction. Form 106 reports theft or significant loss. A patient return placed in a collection receptacle generates neither — collected material is not part of the registrant's inventory and is not counted.

---

4. The Deliberate Exception: Kentucky's Legend Drug Repository

Because 201 KAR 2:190 forecloses ordinary reuse, Kentucky created a statutory channel for donated medication instead. KRS 217.182 and 201 KAR 2:440 (Legend drug repository) establish a repository program allowing eligible entities to accept donated legend drugs and redistribute them to qualifying patients under program conditions rather than through ordinary pharmacy resale.

This is the structural point the exam is testing: Kentucky did not loosen 201 KAR 2:190 to let unused medication be recirculated. It built a separate, supervised program with its own eligibility rules, and left the ordinary reuse prohibition intact. A charitable pharmacy permitted under 201 KAR 2:240 operates in the same policy space — dispensing donated legend drugs to indigent patients, and prohibited from handling controlled substances at all.